Hassan Bruneo is a highly accomplished professional with a diverse skill set and years of experience in the pharmaceutical and healthcare industries. He holds multiple degrees from Politecnico di Milano in biomedical and management engineering, which have been instrumental in his successful career path.
Bruneo's extensive background includes key leadership roles at Alnylam Pharmaceuticals, where he served as the Head of Market Access, Pricing & Policy CEMEA and as the Director of Market Access & Policy, CEMEA. Prior to his work at Alnylam Pharmaceuticals, Bruneo was a Senior Manager and Manager for Global Market Access at Biogen. He has also worked as a Senior Consultant for Simon-Kucher & Partners, Ernst&Young Financial Business Advisory, and KPMG.
Throughout his career, Bruneo has developed a wealth of expertise in healthcare and pharmaceuticals, with a strong focus on market access, pricing, and policy. He has also gained valuable experience in engineering, having worked as an engineer at Lithomobile at Alliance Medical srl.
Bruneo is an exceptional leader and problem-solver, with excellent analytical and strategic thinking skills. He is highly adept at building and sustaining relationships with clients, stakeholders, and team members. Bruneo's passion for healthcare, pharmaceuticals, and engineering has driven his success and continues to inspire him to make a significant impact in his career and industry.